Science Immunology, published by the American Association for the Advancement of Science, is a leading journal in the field of immunology, recognized for its significant impact and rigor in advancing our understanding of immune responses and complex diseases. With an impressive impact factor that places it in the Q1 category of both immunology and allergy, as well as miscellaneous medicine, this journal is ranked #7 and #8 in their respective Scopus categories, reflecting its high-quality research output. Since its inception in 2016, Science Immunology has been at the forefront of interdisciplinary immunological research, fostering crucial insights that link immunology with pressing health challenges. The journal is committed to providing open access to its content, ensuring that groundbreaking findings are accessible to a global audience of researchers, professionals, and students. Its anthology not only addresses fundamental immunological mechanisms but also enhances the dialogue on translational applications and therapeutic interventions, solidifying its position as an essential resource within the scientific community.

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA, an esteemed journal published by SCIENCE PRESS, is a leading platform in the fields of biochemistry, biophysics, and molecular biology. Based in the United Kingdom, this journal has consistently ranked in the Q2 category for Biochemistry, Biophysics, and Medicine (miscellaneous) in 2023, showcasing its commitment to high-quality research and innovation in life sciences. With a convergence period extending from 1996 to 2024, it features critical insights into biochemical and biophysical processes that underlie biological phenomena. Researchers and professionals seeking to stay at the forefront of discoveries will find its articles to be both informative and transformative. Although not an open-access journal, ACTA BIOCHIMICA ET BIOPHYSICA SINICA aims to advance knowledge and foster collaboration among scientists worldwide, emphasizing its role in the dynamic landscape of biomedical research.

JOURNAL OF CELL SCIENCE, with ISSN 0021-9533 and E-ISSN 1477-9137, is a distinguished publication in the field of Cell Biology, released by COMPANY BIOLOGISTS LTD in the United Kingdom. Since its inception in 1966, this journal has served as a vital platform for disseminating cutting-edge research and reviews that significantly advance our understanding of cellular processes and innovations. Currently positioned in the Q1 category within the 2023 rankings, this journal is recognized for its high impact and quality, holding a notable Scopus rank of 120 out of 285 in the Cell Biology category, placing it within the 58th percentile. While not an open-access journal, it provides extensive access options for readers and institutions, ensuring that pivotal research is accessible to a wide audience. With converged publication years leading toward 2024, JOURNAL OF CELL SCIENCE continues to be an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of the intricate workings of cell biology.

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, a reputable journal published by GAKUSHIN PUBL CO, serves as an essential resource for researchers and professionals engaged in the evolving fields of glycoscience and glyotechnology. Established in 1989, this journal has progressively focused on stimulating discussions and disseminating pivotal findings that impact various applications in biochemistry and organic chemistry. With an impressive converge covering decades up to 2024, the journal has carved a niche within the scientific community, despite currently being classified in the lower quartiles (Q4) for its respective categories in 2023. This designation underscores the potential for growth and enhanced visibility within research networks. While it currently operates under a subscription-based model, TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY remains committed to fostering innovation and interdisciplinary collaboration, providing a critical platform for the exploration of glycan structures and functions. Located in Tokyo, Japan, the journal invites contributions that contribute to the future direction of glycoscientific research and its applications.

Journal of Immunology Research, published by HINDAWI LTD, stands as a pivotal open-access journal in the realm of immunology, with a particular emphasis on advancing knowledge in both fundamental and applied aspects of the field. Since its inception in 1990, the journal has committed to the dissemination of high-quality research, earning a respectable impact factor that reflects its significance. Based in Egypt, it provides a platform for researchers from around the world, showcasing innovative studies and reviews that contribute to the understanding of immune system mechanisms. Its 2023 rankings place it in the Q2 category for Immunology and Allergy, and Q1 in the broader category of Medicine (miscellaneous), indicating a strong reputation among its peers. Through its open-access model, the journal promotes wide accessibility of cutting-edge research, catering to researchers, professionals, and students alike. With ambitions that converge through 2024, the Journal of Immunology Research continues to be an essential resource for those seeking to explore the forefront of immunological science.

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.